![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine
Giuseppe A. Palumbo, Daniela Cambria, Enrico La Spina, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 10
Giuseppe A. Palumbo, Daniela Cambria, Enrico La Spina, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 10
Showing 10 citing articles:
Immune Response and Breakthrough Infection Risk After SARS-CoV-2 Vaccines in Patients with Hemoglobinopathy: A Single Center Experience
Andrea Duminuco, Anna Bulla, Rosamaria Rosso, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 111-111
Open Access
Andrea Duminuco, Anna Bulla, Rosamaria Rosso, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 111-111
Open Access
Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses
Annalisa Ciabattini, Elena Pettini, Fabio Fiorino, et al.
EBioMedicine (2025) Vol. 113, pp. 105577-105577
Closed Access
Annalisa Ciabattini, Elena Pettini, Fabio Fiorino, et al.
EBioMedicine (2025) Vol. 113, pp. 105577-105577
Closed Access
ACVR1: A Novel Therapeutic Target to Treat Anemia in Myelofibrosis
Andrea Duminuco, Helen T. Chifotides, Sebastiano Giallongo, et al.
Cancers (2023) Vol. 16, Iss. 1, pp. 154-154
Open Access | Times Cited: 12
Andrea Duminuco, Helen T. Chifotides, Sebastiano Giallongo, et al.
Cancers (2023) Vol. 16, Iss. 1, pp. 154-154
Open Access | Times Cited: 12
Polycythemia Vera: Barriers to and Strategies for Optimal Management
Andrea Duminuco, Patrick Harrington, Claire Harrison, et al.
Blood and Lymphatic Cancer Targets and Therapy (2023) Vol. Volume 13, pp. 77-90
Open Access | Times Cited: 8
Andrea Duminuco, Patrick Harrington, Claire Harrison, et al.
Blood and Lymphatic Cancer Targets and Therapy (2023) Vol. Volume 13, pp. 77-90
Open Access | Times Cited: 8
Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab
Andrea Duminuco, Alessandra Romano, Dario Leotta, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 6
Andrea Duminuco, Alessandra Romano, Dario Leotta, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 6
Emergencies in Hematology: Why, When and How I Treat?
Andrea Duminuco, Vittorio Del Fabro, Luca Patané, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 24, pp. 7572-7572
Open Access | Times Cited: 1
Andrea Duminuco, Vittorio Del Fabro, Luca Patané, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 24, pp. 7572-7572
Open Access | Times Cited: 1
Andrea Duminuco, Adrián Mosquera Orgueira, Antonella Nardo, et al.
Cancer Reports (2023) Vol. 6, Iss. 10
Open Access | Times Cited: 4
Successful SARS-CoV-2 mRNA Vaccination Program in Allogeneic Hematopoietic Stem Cell Transplant Recipients—A Retrospective Single-Center Analysis
Alexander Nikoloudis, Ines Julia Neumann, Veronika Buxhofer‐Ausch, et al.
Vaccines (2023) Vol. 11, Iss. 10, pp. 1534-1534
Open Access | Times Cited: 3
Alexander Nikoloudis, Ines Julia Neumann, Veronika Buxhofer‐Ausch, et al.
Vaccines (2023) Vol. 11, Iss. 10, pp. 1534-1534
Open Access | Times Cited: 3
Longitudinal Immunogenicity Study of SARS-CoV-2 mRNA Vaccines Across Subjects with Different Immunocompromising Conditions: Heterogeneity in the Immune Response and Crucial Role of the Booster Dose
Annalisa Ciabattini, Elena Pettini, Fabio Fiorino, et al.
(2024)
Closed Access
Annalisa Ciabattini, Elena Pettini, Fabio Fiorino, et al.
(2024)
Closed Access
Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib
Francesca Palandri, Elena Maria Elli, Giuseppe Auteri, et al.
Blood Cancer Journal (2023) Vol. 13, Iss. 1
Open Access
Francesca Palandri, Elena Maria Elli, Giuseppe Auteri, et al.
Blood Cancer Journal (2023) Vol. 13, Iss. 1
Open Access
Breakthrough infection after SARS-CoV-2 vaccines in patients with hemoglobinopathies and blood-transfusion management: a single Center experience
Andrea Duminuco, Anna Bulla, Rosamaria Rosso, et al.
Research Square (Research Square) (2023)
Open Access
Andrea Duminuco, Anna Bulla, Rosamaria Rosso, et al.
Research Square (Research Square) (2023)
Open Access